Capital Advantage »

Eli Lilly & Co. shares owned by Capital Advantage

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Capital Advantage from 13F filings

Historical chart of Capital Advantage investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Capital Advantage consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Capital Advantage

Quarter filed Position value Share count Share price at filing
2024-12-31 $441k 571 772.31

More positions owned by Capital Advantage

Vanguard Scottsdale Fds Int-term Corp (VCIT)
Schwab Strategic Tr Fundamental Intl (FNDF)
Vanguard Whitehall Fds Intl Dvd Etf (VIGI)
Vanguard Whitehall Fds Intl High Etf (VYMI)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Specialized Funds Div App Etf (VIG)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard World Health Car Etf (VHT)
Vanguard World Mega Cap Index (MGC)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Vanguard World Industrial Etf (VIS)
Apple (AAPL)
Spdr Ser Tr Portfolio S&p500 (SPLG)

View all positions for Capital Advantage

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
Pnc Financial Services
State Street Corporation
FMR
T. Rowe Price Associates
Capital World Investors
Geode Capital Management
PRIMECAP Management Company
Jpmorgan Chase & Co
Morgan Stanley
State Farm Mutual Automobile Insurance Company
Wellington Management Company
Norges Bank Investment Management

View all funds holding Eli Lilly & Co.